Iterum Therapeutics plc (NASDAQ:ITRM) Short Interest Update

Iterum Therapeutics plc (NASDAQ:ITRM – Get Free Report) was the recipient of a large growth in short interest during the month of August. As of August 15th, there was short interest totalling 85,700 shares, a growth of 72.8% from the July 31st total of 49,600 shares. Currently, 0.7% of the company’s shares are short sold. […]

Related Keywords

United States ,Bermuda ,Ireland , ,Iterum Therapeutics Company Profile ,Goldman Sachs Group Inc ,Nasdaq ,Renaissance Technologies ,Dimensional Fund Advisors ,Apollon Wealth Management ,Iterum Therapeutics ,Get Free Report ,Therapeutics Trading Down ,Fund Advisors ,Wealth Management ,Sachs Group ,Iterum Therapeutics Daily ,Nasdaq Itrm ,Itrm ,Medical ,Stocks ,Options ,Put ,Call ,